Related Experiment Video
Updated: Apr 28, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Roles of Fas/Fasl, Bcl-2/Bax, and Caspase-8 in rat nonalcoholic fatty liver disease pathogenesis
1Department of Gastroenterology, The Affiliated Hospital of Luzhou Medical College, Luzhou, China changpinglicn@126.com.
Abstract:
The aim of this study was to investigate the roles of Fas/FasL, Bcl-2/Bax, and Caspase-8 mRNA expressions in nonalcoholic fatty liver disease (NAFLD). The apoptosis percentage was measured by flow cytometry, the immunohistochemical assay was performed for the determination of Fas, FasL, Bcl-2, and Bax expressions, and a real-time polymerase chain reaction (PCR) assay was performed to detect Caspase-8 mRNA expression. Flow cytometry showed that the apoptosis percentage of the rat liver in the experimental group increased, which increased more obviously with the extension of modeling time. Immunohistochemistry showed that with increasing hepatic steatosis, Fas and FasL protein staining intensified and the number of positive cells increased; the number of positive cells for Bcl-2 and Bax gradually increased on the 4th, 8th, and 12th weeks in the experimental group, whereas the Bcl-2/Bax ratio decreased. The real-time PCR assay showed that Caspase-8 mRNA expression increased with increasing hepatic steatosis and inflammation, exhibiting a progressively rising trend. Hepatocyte apoptosis could promote NAFLD progression; Fas, FasL, and Caspase-8 mRNA activation were important contributing factors to NAFLD. The upregulation of Bax and Bcl-2 expression might be one important mechanism of the apoptosis in NAFLD.
Insights
Hepatocyte apoptosis promotes nonalcoholic fatty liver disease (NAFLD) progression. Key factors include increased Fas, FasL, and Caspase-8 mRNA, alongside altered Bcl-2/Bax ratios, contributing to NAFLD development.
Area of Science:
- Hepatology
- Molecular Biology
- Cellular Biology
Background:
- Nonalcoholic fatty liver disease (NAFLD) is a growing health concern.
- Hepatocyte apoptosis plays a role in NAFLD pathogenesis.
- The specific molecular mechanisms driving apoptosis in NAFLD require further elucidation.
Purpose of the Study:
- To investigate the expression of Fas/FasL, Bcl-2/Bax, and Caspase-8 mRNA in NAFLD.
- To correlate apoptosis levels with disease progression in a NAFLD rat model.
- To identify key molecular players involved in NAFLD-associated apoptosis.
Main Methods:
- Flow cytometry to quantify hepatocyte apoptosis percentage.
- Immunohistochemistry to assess Fas, FasL, Bcl-2, and Bax protein expression.
- Real-time PCR to measure Caspase-8 mRNA levels.
Main Results:
- Apoptosis percentage significantly increased in NAFLD rat livers, correlating with disease duration.
- Fas and FasL protein expression and positive cell counts intensified with hepatic steatosis.
- Bcl-2 and Bax positive cell counts increased, leading to a decreased Bcl-2/Bax ratio; Caspase-8 mRNA expression rose with steatosis and inflammation.
Conclusions:
- Hepatocyte apoptosis is a significant driver of NAFLD progression.
- Fas/FasL and Caspase-8 mRNA activation are crucial contributors to NAFLD.
- Upregulation of Bax and Bcl-2 expression represents a potential mechanism for apoptosis in NAFLD.
Related Concept Videos
Cirrhosis II: Pathophysiology
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Chronic Pancreatitis II: Pathophysiology
Cirrhosis I: Introduction

